The reproductive conditions and lipid profile in females with epilepsy.
OBJECTIVE
To explore the reproductive conditions in women with epilepsy.


METHODS
Eighty-eight women were included; 37.5% and 62.5% had generalized and partial epilepsies, respectively. Ovarian sonogram, reproductive hormone and lipid profiles were assessed.


RESULTS
Compared with the control group and in accordance with our laboratory reference values, irregular menses and polycystic ovaries (PCO(s)) were reported in 70.5% and 39.8% versus 21.7% and 16.7% of controls. Abnormalities in leutinizing hormone (LH), follicle-stimulating hormone (FSH), LH-to-FSH ratio, testosterone (T) and prolactin (PRL) were identified. High values of FSH, LH and FSH-to-LH ratio were common with carbamazepine while that of T and PRL were common in untreated patients and with valproate. Low levels of high-density lipoprotein cholesterol was identified in approximately 59% but neither associated with duration and type of antiepileptic drugs nor patients' age, hormonal profile or PCO(s). Significant correlation was identified between menatrual irregularities, T, PRL, hormonal, lipid profile alterations, PCO(s) and seizure frequency but neither with epilepsy type nor focus.


CONCLUSIONS
This is the first study in our country that aimed at evaluation of reproductive conditions in women with epilepsy. This study indicates that reproductive dysfunction is common, hence, characterization of seizure-associated neuroendocrine adverse effects is important while managing women particularly during choice of antiepileptic medications as initial step and during patients' follow-up.
Hamed
S A
SA
Department of Neurology, Assiut University, Assiut, Egypt. hamed_sherifa@yahoo.com
Hamed
E A
EA
Shokry
M
M
Omar
H
H
Abdellah
M M
MM
D000328:Adult; D000568:Amenorrhea / Q000453:epidemiology*; D000927:Anticonvulsants / Q000627:therapeutic use; D016022:Case-Control Studies; D004534:Egypt; D004827:Epilepsy / Q000097:blood* / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D011085:Polycystic Ovary Syndrome / Q000453:epidemiology*; D015995:Prevalence; D013739:Testosterone / Q000097:blood
D000927:Anticonvulsants; D006065:Gonadotropins, Pituitary; D008055:Lipids; D013739:Testosterone